{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:10:29Z","timestamp":1788689429240,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-026-00809-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:23:24Z","timestamp":1780392204000},"page":"487-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotype-Guided Renal Denervation: the Key to Therapeutic Response"],"prefix":"10.1007","volume":"33","author":[{"given":"Ehsan","family":"Shahverdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Roman","family":"Herda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sendooran","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"809_CR1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk factors collaborators. Global burden of hypertension and risk factors. Lancet. 2020;396:1223\u201349.","journal-title":"Lancet"},{"key":"809_CR2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure. Lancet. 2002;360:1903\u201313.","journal-title":"Lancet"},{"key":"809_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension control. Circulation. 2016;134:441\u201350.","journal-title":"Circulation"},{"key":"809_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.phrs.2017.08.015","volume":"125","author":"M Burnier","year":"2017","unstructured":"Burnier M, Egan BM. Adherence in hypertension. Pharmacol Res. 2017;125:142\u20139.","journal-title":"Pharmacol Res"},{"key":"809_CR5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Vrijens","year":"2018","unstructured":"Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence. J Hypertens. 2018;36:1953\u201364.","journal-title":"J Hypertens"},{"key":"809_CR6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/01.hjh.0000198036.16634.1a","volume":"24","author":"M Esler","year":"2006","unstructured":"Esler M, Lambert G, Schlaich M. Sympathetic nervous system and hypertension. J Hypertens. 2006;24:1045\u201352.","journal-title":"J Hypertens"},{"key":"809_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.109.138610","volume":"54","author":"MP Schlaich","year":"2009","unstructured":"Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic nerve activity. Hypertension. 2009;54:1195\u2013201.","journal-title":"Hypertension"},{"key":"809_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal denervation. Lancet. 2009;373:1275\u201381.","journal-title":"Lancet"},{"key":"809_CR9","first-page":"23430669","volume":"PMID","author":"M Volpe","year":"2012","unstructured":"Volpe M, et al. Renal artery denervation for treating resistant hypertension. High Blood Press Cardiovasc Prev. 2012;PMID:23430669.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"809_CR10","doi-asserted-by":"publisher","unstructured":"Bruno RM, Taddei S, Borghi C et al. Italian Society of Arterial Hypertension (SIIA) position paper on the role of renal denervation in the management of the difficult-to-treat hypertensive patient. High Blood Press Cardiovasc Prev. 2020;27:109\u2013117. https:\/\/doi.org\/10.1007\/s40292-020-00367-0.","DOI":"10.1007\/s40292-020-00367-0"},{"key":"809_CR11","unstructured":"Barbato E et al. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC council on hypertension and the european association of percutaneous cardiovascular interventions. European Heart J. 2023;44(15):1313\u20131330.2023."},{"key":"809_CR12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"Symplicity HTN-1 Investigators","year":"2010","unstructured":"Symplicity HTN-1 Investigators. Renal denervation in resistant hypertension. Lancet. 2010;376:1903\u20139.","journal-title":"Lancet"},{"key":"809_CR13","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"Symplicity HTN-2 Investigators","year":"2010","unstructured":"Symplicity HTN-2 Investigators. Renal denervation trial. Lancet. 2010;376:1903\u20139.","journal-title":"Lancet"},{"key":"809_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh KJ, Townsend RR, Bakris GL. Symplicity HTN-3 trial. N Engl J Med. 2014;370:1393\u2013401.","journal-title":"N Engl J Med"},{"key":"809_CR15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jacc.2015.08.910","volume":"66","author":"DE Kandzari","year":"2015","unstructured":"Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL. Predictors of response in HTN-3. J Am Coll Cardiol. 2015;66:286\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"809_CR16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000033","volume":"66","author":"RR Townsend","year":"2015","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Schmieder RE, Tsioufis K, Doumas M, Schlaich MP. Methodological issues in renal denervation. Hypertension. 2015;66:1269\u201375.","journal-title":"Hypertension"},{"key":"809_CR17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.07.937","volume":"64","author":"AR Tzafriri","year":"2014","unstructured":"Tzafriri AR, Mahfoud F, Keating JH, Markham PM, Spognardi AM, Wong G, B\u00f6hm M, Kirtane AJ, Leon MB. Renal nerve anatomy. J Am Coll Cardiol. 2014;64:635\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"809_CR18","first-page":"222","volume":"69","author":"F Mahfoud","year":"2017","unstructured":"Mahfoud F, Tunev S, Ewen S, Cremers B, Ruwart J, Schulz-Juergensen S, Wellhoefer E, Laule M, Ott C, B\u00f6hm M. Distal renal denervation. Hypertension. 2017;69:222\u201330.","journal-title":"Hypertension"},{"key":"809_CR19","first-page":"1505","volume":"396","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, Nickenig G, Schmieder RE. Long-term safety of renal denervation. Lancet. 2020;396:1505\u201316.","journal-title":"Lancet"},{"key":"809_CR20","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Schmieder RE, Tsioufis K, Doumas M, Schlaich MP. Spyral HTN-off med trial. Lancet. 2017;390:2160\u201370.","journal-title":"Lancet"},{"key":"809_CR21","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","volume":"391","author":"DE Kandzari","year":"2018","unstructured":"Kandzari DE, B\u00f6hm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Spyridopoulos I. Spyral HTN-on med trial. Lancet. 2018;391:2346\u201355.","journal-title":"Lancet"},{"key":"809_CR22","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","volume":"391","author":"M Azizi","year":"2018","unstructured":"Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD. Radiance-HTN solo trial. Lancet. 2018;391:2335\u201345.","journal-title":"Lancet"},{"key":"809_CR23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/eurheartj\/ehab724.2376","volume":"42","author":"F Mahfoud","year":"2021","unstructured":"Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, B\u00f6hm M. Heterogeneity of response to RDN. Eur Heart J. 2021;42:1196\u2013204.","journal-title":"Eur Heart J"},{"key":"809_CR24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.12097","volume":"73","author":"RE Schmieder","year":"2019","unstructured":"Schmieder RE, Ott C, Toennes SW, Scholz S, Friedrich S, Bramlage P. Predictors of BP response to RDN. Hypertension. 2019;73:650\u20138.","journal-title":"Hypertension"},{"key":"809_CR25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/HJH.0000000000002327","volume":"38","author":"E Warcho\u0142-Celi\u0144ska","year":"2020","unstructured":"Warcho\u0142-Celi\u0144ska E, Prejbisz A, Kadziela J, Florczak E, Januszewicz A. Patient characteristics and RDN response. J Hypertens. 2020;38:112\u201320.","journal-title":"J Hypertens"},{"key":"809_CR26","first-page":"181","volume":"79","author":"C Ott","year":"2022","unstructured":"Ott C, Mahfoud F, Schmid A, Schmieder RE. BP phenotype and renal denervation. Hypertension. 2022;79:181\u20139.","journal-title":"Hypertension"},{"key":"809_CR27","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I. Device-based therapies for hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"809_CR28","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SC, Taler SJ, Textor SC, Turan TN, White WB. Resistant hypertension statement. Hypertension. 2018;72:e53\u201390.","journal-title":"Hypertension"},{"key":"809_CR29","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","volume":"51","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D. Resistant hypertension definition. Hypertension. 2008;51:1403\u201319.","journal-title":"Hypertension"},{"key":"809_CR30","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","volume":"57","author":"A de la Sierra","year":"2011","unstructured":"de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM. White-coat effect in resistant HTN. Hypertension. 2011;57:898\u2013902.","journal-title":"Hypertension"},{"key":"809_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","volume":"32","author":"G Parati","year":"2014","unstructured":"Parati G, Stergiou G, O\u2019Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head G, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Niiranen T, Ogedegbe G, Ohkubo T, Omboni S, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Verdecchia P, Wang J, Zanchetti A. ABPM guidelines. J Hypertens. 2014;32:1359\u201366.","journal-title":"J Hypertens"},{"key":"809_CR32","first-page":"462","volume":"72","author":"JR Banegas","year":"2018","unstructured":"Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, Ruiz-Hurtado G, Segura J, Rodriguez-Artalejo F. ABPM prognosis. Hypertension. 2018;72:462\u201371.","journal-title":"Hypertension"},{"key":"809_CR33","first-page":"1319","volume":"64","author":"M Tomaszewski","year":"2014","unstructured":"Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, Samani NJ, Gupta P. Non-adherence prevalence. Hypertension. 2014;64:1319\u201327.","journal-title":"Hypertension"},{"key":"809_CR34","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.117.09631","volume":"70","author":"P Gupta","year":"2017","unstructured":"Gupta P, Patel P, \u0160trauch B, Lai FY, Akbarov A, Maresova V, Tomaszewski M. Adherence and placebo effects. Hypertension. 2017;70:1046\u201354.","journal-title":"Hypertension"},{"key":"809_CR35","first-page":"1517","volume":"396","author":"M Burnier","year":"2020","unstructured":"Burnier M, Egan BM. Adherence-independent BP therapies. Lancet. 2020;396:1517\u20138.","journal-title":"Lancet"},{"key":"809_CR36","first-page":"1252","volume":"75","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Pocock S. Baseline BP and RDN response. Hypertension. 2020;75:1252\u20139.","journal-title":"Hypertension"},{"key":"809_CR37","first-page":"832","volume":"7","author":"K Sakakura","year":"2014","unstructured":"Sakakura K, Ladich E, Cheng Q, Yahagi K, Kolodgie FD, Virmani R. Renal artery anatomy. Circ Cardiovasc Interv. 2014;7:832\u20139.","journal-title":"Circ Cardiovasc Interv"},{"key":"809_CR38","first-page":"341","volume":"57","author":"PA Sobotka","year":"2011","unstructured":"Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, B\u00f6hm M, Krum H. Accessory renal arteries. Hypertension. 2011;57:341\u20137.","journal-title":"Hypertension"},{"key":"809_CR39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jcin.2019.03.010","volume":"12","author":"K Fengler","year":"2019","unstructured":"Fengler K, Rommel KP, Blazek S, Besler C, Hartung P, von Roeder M, Petzold M, Thiele H, Linke A. Branch vessel ablation. JACC Cardiovasc Interv. 2019;12:790\u2013802.","journal-title":"JACC Cardiovasc Interv"},{"key":"809_CR40","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","volume":"327","author":"RL Converse","year":"1992","unstructured":"Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic activity in CKD. N Engl J Med. 1992;327:1912\u20138.","journal-title":"N Engl J Med"},{"key":"809_CR41","first-page":"1056","volume":"108","author":"MG Kiuchi","year":"2019","unstructured":"Kiuchi MG, Graciano ML, Carreira MA, Kiuchi T, Chen S. Renal function after RDN. Clin Res Cardiol. 2019;108:1056\u201364.","journal-title":"Clin Res Cardiol"},{"key":"809_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/HYPERTENSIONAHA.119.12885","volume":"74","author":"G Grassi","year":"2019","unstructured":"Grassi G, Mark A, Esler M. Obesity and sympathetic activation. Hypertension. 2019;74:127\u201334.","journal-title":"Hypertension"},{"key":"809_CR43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.118.11180","volume":"72","author":"E Warcho\u0142-Celi\u0144ska","year":"2018","unstructured":"Warcho\u0142-Celi\u0144ska E, Kadziela J, Prejbisz A, Florczak E, Januszewicz A. RDN in sleep apnea. Hypertension. 2018;72:113\u201320.","journal-title":"Hypertension"},{"key":"809_CR44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/HYPERTENSIONAHA.120.16531","volume":"77","author":"GS Stergiou","year":"2021","unstructured":"Stergiou GS, Palatini P, Asmar R, Ioannidis JP, Kollias A, Lacy P, McManus RJ, Myers MG, Parati G, Shennan A. ABPM thresholds. Hypertension. 2021;77:129\u201337.","journal-title":"Hypertension"},{"key":"809_CR45","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/HYPERTENSIONAHA.118.10971","volume":"71","author":"K Kario","year":"2018","unstructured":"Kario K, Shin J, Chen CH, Buranakitjaroen P, Chia YC, Divinagracia R, Nailes J, Park S, Siddique S, Sison J. Nocturnal hypertension. Hypertension. 2018;71:997\u20131003.","journal-title":"Hypertension"},{"key":"809_CR46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/HJH.0000000000000914","volume":"34","author":"C Ukena","year":"2016","unstructured":"Ukena C, Mahfoud F, Spies A, Kindermann I, B\u00f6hm M. Nighttime BP effects of RDN. J Hypertens. 2016;34:1232\u20138.","journal-title":"J Hypertens"},{"key":"809_CR47","first-page":"194","volume":"73","author":"S Ewen","year":"2019","unstructured":"Ewen S, Cremers B, Meyer MR, Donazzan L, Kindermann I, B\u00f6hm M, Mahfoud F. Circadian BP and RDN. Hypertension. 2019;73:194\u2013202.","journal-title":"Hypertension"},{"key":"809_CR48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahl\u00f6f B, Sever PS, Poulter NR. Blood pressure variability. Lancet. 2010;375:895\u2013905.","journal-title":"Lancet"},{"key":"809_CR49","first-page":"684","volume":"62","author":"D Hering","year":"2013","unstructured":"Hering D, Marusic P, Duval J, Sata Y, Head GA, Walton AS, Lambert GW, Esler MD, Schlaich MP. BP variability after RDN. Hypertension. 2013;62:684\u201390.","journal-title":"Hypertension"},{"key":"809_CR50","first-page":"2120","volume":"33","author":"G Grassi","year":"2015","unstructured":"Grassi G, Seravalle G, Quarti-Trevano F, Dell\u2019Oro R, Bombelli M, Mancia G. Sympathetic markers. J Hypertens. 2015;33:2120\u20136.","journal-title":"J Hypertens"},{"key":"809_CR51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/HYPERTENSIONAHA.113.02439","volume":"63","author":"M Esler","year":"2014","unstructured":"Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Measurement of sympathetic activity. Hypertension. 2014;63:423\u20139.","journal-title":"Hypertension"},{"key":"809_CR52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.116.06582","volume":"69","author":"E Lambert","year":"2017","unstructured":"Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Schlaich M. Sympathetic phenotyping. Hypertension. 2017;69:5\u201312.","journal-title":"Hypertension"},{"key":"809_CR53","first-page":"126","volume":"102","author":"JP Howard","year":"2016","unstructured":"Howard JP, Nowbar AN, Francis DP. Reanalysis of HTN-3. Heart. 2016;102:126\u201333.","journal-title":"Heart"},{"key":"809_CR54","first-page":"1249","volume":"75","author":"M Azizi","year":"2020","unstructured":"Azizi M, Sanghvi K, Saxena M. Sham-controlled insights. Hypertension. 2020;75:1249\u201351.","journal-title":"Hypertension"},{"key":"809_CR55","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. BP lowering and CV risk. Lancet. 2016;387:957\u201367.","journal-title":"Lancet"},{"key":"809_CR56","first-page":"513","volume":"19","author":"F Mahfoud","year":"2022","unstructured":"Mahfoud F, B\u00f6hm M, Schmieder R, Narkiewicz K, Ewen S, Williams B. Positioning renal denervation. Nat Rev Cardiol. 2022;19:513\u201327.","journal-title":"Nat Rev Cardiol"},{"key":"809_CR57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/hyp.74.suppl_1.P172","volume":"74","author":"MA Weber","year":"2019","unstructured":"Weber MA, Kirtane AJ, Weir MR, Ruilope LM, Schmieder RE, Townsend RR. Renal outcomes after RDN. Hypertension. 2019;74:526\u201334.","journal-title":"Hypertension"},{"key":"809_CR58","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.jacc.2015.09.081","volume":"66","author":"JB Pietzsch","year":"2015","unstructured":"Pietzsch JB, Geisler BP, Garner AM, Uhl S, Heidenreich PA. Cost-effectiveness of RDN. J Am Coll Cardiol. 2015;66:2683\u201392.","journal-title":"J Am Coll Cardiol"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-026-00809-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:02:36Z","timestamp":1788688956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-026-00809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1007\/s40292-026-00809-1","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"1 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}